Connecticut Innovations

Founded in 1989, Connecticut Innovations supports high-tech companies by providing strategic capital and operational insight. They focus on energy, biotechnology, information technology, and photonics sectors, offering flexible financing, guidance, and valuable partnerships to enable growth.

Matthew J. Archuleta

Senior Associate, Investments

Matthew Bloom

Managing Director

Lauren Carmody

Chief Marketing Officer

Kevin Crowley

Managing Director

Tamyra Davis

Senior Investment Specialist

Ryan Dings

Venture Partner

Brian Dowd

Director, Investments

Drew D’Alelio

Senior Associate, Investments

Cyndi Green

Managing Director

Peter Longo

Managing Director

Jordan Lue

Analyst, Investments

Alison Malloy

Managing Director

Pauline Murphy

Managing Director

Patrick O'Neill

Managing Director

Malik D. Okoro

Senior Associate, Investments

Matt Panicali

Associate, Investments

Antonio Roberto

Managing Director, Strategic Investments

Douglas Roth

Managing Director

Philip Siuta

COO and CFO

Matthew Storeygard

Managing Director

Anil Vasagir

Director of Investments

Daniel Wagner

Managing Director

Renee Wasko

Associate, Investments

David Wurzer

Vice President

Wenping Zhou

Associate

Past deals in Connecticut

Normunity

Series B in 2025
Normunity is a biotechnology company that develops precision immuno‑oncology medicines, termed immune normalizers, designed to restore the body’s natural immune response against cancer. Leveraging a partnership with Dr. Lieping Chen’s laboratory at Yale School of Medicine, the company focuses on newly discovered mechanisms of immune disruption, such as the exclusion of T‑cells from immune‑sensitive tumors and other barriers to normal immune function. Its pipeline includes programs targeting these mechanisms to enable clinicians to treat cancer by reactivating the patient’s own immunity. Normunity operates from offices in Boston, Massachusetts, and West Haven, Connecticut.

Quantum Circuits

Venture Round in 2024
Founded in 2015 by Dr. Robert Schoelkopf, Quantum Circuits develops and manufactures quantum computers based on superconducting devices. The company focuses on creating full-stack quantum computers designed for efficient scaling, with a pioneering approach to error detection and correction.

IntelliBoard

Venture Round in 2023
IntelliBoard, Inc. is a technology company based in Monroe, Connecticut, founded in 2015. It specializes in developing a learning analytics platform that serves educational institutions and corporate clients by providing insightful reporting and data analysis. The platform integrates with various Learning Management Systems to deliver real-time data on learner engagement, performance, and the effectiveness of educational content. By transforming raw data into accessible and visually appealing reports, including charts and graphs, IntelliBoard empowers educators and administrators to make informed decisions that enhance learning outcomes and operational efficiency. Its focus on both higher education and corporate training allows IntelliBoard to support clients in achieving their educational goals and optimizing their e-learning investments.

Slooh

Venture Round in 2023
Slooh is an online astronomy platform that connects robotic telescopes to the Internet, enabling live viewing, real-time celestial imaging, and educational exploration for the public and educators. Founded in 2003, Slooh operates flagship observatories and partners with institutions in locations such as Mt. Teide in the Canary Islands and in Chile, with live broadcasts from partner sites worldwide. Its automated observatories develop celestial images for Internet broadcast and support educational programs and media partnerships, making space exploration accessible to K-12 students, enthusiasts, and the general audience. The service collaborates with scientific institutions and engages in agreements to advance public access to space observations.

Inbox Health

Series B in 2023
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

Torigen Pharmaceuticals

Venture Round in 2022
Founded in 2013, Torigen Pharmaceuticals specializes in developing innovative cancer care solutions for pets. Based in Farmington, Connecticut, the company focuses on advancing scientific research to bring novel approaches to companion animal cancers.

Source Defense

Series B in 2022
Source Defense Ltd. is a cybersecurity company specializing in website security software that prevents attacks originating from third-party sources. Founded in 2014 and headquartered in Rosh-ha’ayin, Israel, with additional offices in Beer-Sheva and Stamford, Connecticut, the company offers a cloud-based Software-as-a-Service platform. This platform enables site owners to effectively manage their security by setting and enforcing permissions, receiving real-time alerts, and monitoring the activities of third-party vendors on their sites. Source Defense aims to eliminate the security risks associated with third-party integrations, allowing businesses to save significant time and resources while maintaining high performance and safety for site visitors. Its tailored solutions include VICE products designed for various sectors, including financial institutions, insurance companies, e-commerce, and publishing.

NourishedRx

Seed Round in 2022
Founded in Stamford, Connecticut in 2019, NourishedRx specializes in personalized nutrition solutions for health plan members with diet-sensitive chronic conditions or at risk of nutrition insecurity. They provide tailored meal plans and education to improve clinical outcomes and reduce healthcare costs.

Wellinks

Series C in 2021
Wellinks specializes in wearable health technologies designed to enhance clinical outcomes. Founded in 2014, the company is renowned for its innovative smart strap that monitors scoliosis brace wear duration and tightness, empowering patients, parents, and doctors with real-time data for informed treatment decisions.

Lumeda

Series A in 2021
Lumeda Inc. is a biotechnology company based in Rocky Hill, Connecticut, founded in 2020. It specializes in developing advanced photonic tools that facilitate intraoperative photodynamic therapy (PDT) for lung cancer treatment. Lumeda's innovative solutions include light delivery instrumentation and proprietary software designed to automate the PDT light delivery process, targeting tumor sites with precision and enhancing treatment efficacy. The company's technology aims to improve the planning and delivery of PDT, offering a more streamlined and effective approach during non-small cell lung cancer surgeries. By integrating advanced photonics and AI-driven software, Lumeda enhances the consistency and reliability of PDT, ultimately aiming to reduce post-operative recurrence and improve patient outcomes. The company collaborates closely with leading medical institutions to advance its solutions in clinical settings.

Inbox Health

Series A in 2021
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

Artizan Biosciences

Series A in 2021
Artizan Biosciences, Inc. is a biotechnology company focused on developing small molecule drugs for human use, particularly targeting diseases linked to intestinal inflammation. Founded in 2016 and headquartered in New Haven, Connecticut, the company employs its proprietary IgA-SEQ technology platform to identify and characterize disease-driving bacteria within the intestinal microbiota. This innovative approach aims to create precision therapeutics that address the root causes of various serious conditions, including digestive disorders, obesity, autoimmune diseases, and a range of other health issues affecting the skin, lungs, and central nervous system. By focusing on unmet medical needs, Artizan Biosciences seeks to provide novel treatment options for patients.

Biorez

Seed Round in 2020
Biorez is a medical device company that develops bioresorbable scaffold implants to regenerate functional musculoskeletal tissue in vivo. Its products include off-the-shelf implants for anterior cruciate ligament reconstruction that spare donor tissue, and PLLA-based devices for soft-tissue regeneration in the knee, such as the L-C Ligament; the company also markets GRAFT, an FDA 510(k)-cleared device for soft-tissue augmentation of the rotator cuff, along with related implants to support repairs during healing. Biorez uses poly-L-lactic acid polymers to stabilize surgical repairs while the body regenerates tissue, enabling rehabilitation. The company was founded in 2008 and is headquartered in New Haven, Connecticut.

Simcha Therapeutics

Series A in 2020
Simcha Therapeutics is a biopharmaceutical company focused on developing engineered cytokine immunotherapy for cancer treatment. Founded in 2018 and headquartered in New Haven, Connecticut, the company utilizes directed evolution to create novel cytokines that enhance the immune system's ability to combat diseases. Its lead program, ST-067, is a designer IL-18 cytokine that has demonstrated significant antitumor effects in animal models, both as a standalone treatment and in combination with anti-PD-1 checkpoint inhibitors. This innovative approach aims to provide patients with more effective immunotherapies, thereby improving their ability to fight cancer.

IntelliBoard

Series A in 2020
IntelliBoard, Inc. is a technology company based in Monroe, Connecticut, founded in 2015. It specializes in developing a learning analytics platform that serves educational institutions and corporate clients by providing insightful reporting and data analysis. The platform integrates with various Learning Management Systems to deliver real-time data on learner engagement, performance, and the effectiveness of educational content. By transforming raw data into accessible and visually appealing reports, including charts and graphs, IntelliBoard empowers educators and administrators to make informed decisions that enhance learning outcomes and operational efficiency. Its focus on both higher education and corporate training allows IntelliBoard to support clients in achieving their educational goals and optimizing their e-learning investments.

CytoVeris

Venture Round in 2020
CytoVeris develops optical-based technologies that assist surgical oncologists in identifying and removing tumor tissue during cancer resection surgery. Its devices enhance surgeons' ability to achieve clean margins, while its OncoMap system detects molecular signatures unique to cancer cells. Founded by Alan Kersey in Farmington, Connecticut in 2018.

Mindnest Health

Seed Round in 2020
MindNest Health, Inc. is a New Haven, Connecticut-based company that develops a digital platform designed to provide parents with access to clinically validated behavioral interventions for their children. Founded in 2016, MindNest Health focuses on addressing various developmental challenges, offering programs specifically for ADHD, autism, and disruptive behaviors, as well as training modules aimed at anxiety and substance abuse. The platform aims to support parents during critical times when they seek assistance for their children's mental health, thereby reducing barriers to care and alleviating parental stress. By providing evidence-based solutions, MindNest Health envisions fostering an environment where children can reach their full potential and families can thrive.

Inbox Health

Venture Round in 2020
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

P2 Science

Series C in 2020
Founded in 2009 by Yale scientists and a chemical industry veteran, P2 Science is a venture-backed company specializing in renewable specialty chemicals. It converts renewable feedstocks like vegetable oils into high-value products such as flavor, fragrance, and cosmetics ingredients, serving diverse markets including food, personal care, and industrial cleaning.

Enviro Power

Series A in 2020
Enviro Power, LLC is a Connecticut-based company that specializes in developing and marketing innovative heating equipment for both residential and commercial applications. Founded in 2013, the company features its flagship SmartWatt Boiler technology platform, which is designed to generate electricity at near-zero costs while meeting heating demands. This advanced system transforms conventional heating infrastructure into a dual-purpose energy platform, enabling building owners to benefit from reduced utility bills and enhanced grid resiliency. By providing backup power and supporting grid stability, Enviro Power aims to lower carbon footprints and improve energy efficiency for millions of users.

IsoPlexis

Series C in 2020
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

BioWave Corporation

Venture Round in 2020
BioWave Corporation develops and markets neuromodulation medical devices that deliver therapeutic electrical signals through the skin to block pain at its source. Its product family includes BioWavePRO and BioWaveHOME for prescription use, and BioWaveGO for over-the-counter relief, along with BioWavePENS percutaneous electrodes and reusable noninvasive electrodes and accessories. The devices target chronic, acute, and postoperative musculoskeletal and neuropathic pain, providing relief by interrupting pain signal transmission to the brain. The company serves pain doctors, pro athletes, U.S. veterans and active military personnel, and others seeking non-pharmacological pain treatment. Founded in 1997 and based in Norwalk, Connecticut, BioWave emphasizes non-pharmacological pain relief through electrical nerve modulation, with options for clinic and home use.

Wellinks

Series B in 2019
Wellinks specializes in wearable health technologies designed to enhance clinical outcomes. Founded in 2014, the company is renowned for its innovative smart strap that monitors scoliosis brace wear duration and tightness, empowering patients, parents, and doctors with real-time data for informed treatment decisions.

Budderfly

Venture Round in 2019
Budderfly, Inc. is an energy management company that specializes in designing and implementing innovative solutions for optimizing energy consumption. Founded in 2007 and based in Shelton, Connecticut, Budderfly offers a comprehensive range of hardware and software solutions, including a proprietary energy intelligence software platform. This platform enables clients to manage various aspects of energy usage, such as voltage management, energy billing, and peak demand management. Budderfly also integrates a network of IoT devices, LED lighting, HVAC controls, and other energy-efficient technologies to enhance energy efficiency across diverse facilities, including office buildings, schools, and healthcare facilities. By employing an Energy-as-a-Service model, Budderfly provides its services at no upfront cost to clients, resulting in immediate and ongoing energy savings, upgraded infrastructure, and a reduced carbon footprint.

Inbox Health

Seed Round in 2019
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

Cybrexa Therapeutics

Series B in 2019
Cybrexa Therapeutics is a biotechnology company focused on developing an innovative class of small molecule DNA repair inhibitors aimed at improving cancer treatment. Founded in 2016 and based in New Haven, Connecticut, Cybrexa utilizes a proprietary peptide-based technology that specifically targets the tumor microenvironment. This approach allows for enhanced drug delivery and increased therapeutic efficacy, particularly when combined with existing chemotherapies and radiotherapies. By enabling the safe administration of higher drug doses, Cybrexa's therapeutics aim to expand the efficacy of current anticancer agents and address significant unmet medical needs in oncology. The company's novel platform has the potential to redefine drug delivery paradigms and enhance patient outcomes in cancer care.

PayVeris

Series D in 2019
PayVeris, LLC is a cloud-based digital payment and money transfer platform that provides comprehensive solutions for both consumer and business bill payments, as well as external account-to-account transfers between various financial institutions. Founded in 2011 and headquartered in Cromwell, Connecticut, PayVeris enables person-to-person payments, allowing users to send money electronically from their bank or credit union accounts via web, smartphone, or tablet. The platform includes PayWatch, an integrated fraud prevention solution that monitors transactions for potential risks, and PayItNow, a service that connects financial institutions, merchants, and consumers in the payments process. PayVeris has established strategic partnerships with Kony and Corelation to enhance its offerings and expand its reach in the digital payments landscape.

IsoPlexis

Series C in 2019
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

Allyx Therapeutics

Convertible Note in 2019
Allyx Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2018 and based in Durham, Connecticut. The company specializes in developing disease-modifying treatments for Alzheimer's Disease, with a focus on reversing neurodegeneration. Its lead product is an orally bioavailable small molecule that functions as a silent allosteric modulator of mGluR5. This innovative approach aims to provide clinicians with a therapeutic option capable of preserving cognition in patients while addressing the underlying disease mechanisms.

Torigen Pharmaceuticals

Series A in 2019
Founded in 2013, Torigen Pharmaceuticals specializes in developing innovative cancer care solutions for pets. Based in Farmington, Connecticut, the company focuses on advancing scientific research to bring novel approaches to companion animal cancers.

Phlatbed

Venture Round in 2019
Phlatbed Inc. is an on-demand logistics application founded in 2016 and based in Norwalk, Connecticut. The platform connects consumers with local drivers who offer services for moving, packing, loading, and junk removal. Users can place real-time requests and select from multiple drivers based on geographic preferences, service pricing, and availability. Once a driver is accepted, payment is processed automatically through PayPal, credit card, or cash, and both parties can provide feedback on their experience. Phlatbed operates across the United States, Canada, and is expanding into the United Kingdom. The company promotes community engagement through an active blog and social media presence, aiming to eliminate waste and help individuals turn idle assets into revenue.

Bactana Corporation

Series A in 2019
Bactana Corporation develops a nutritional product platform aimed at enhancing microbiome health in livestock and other animals. Its core product, FPS-4, manipulates immunometabolism to boost productivity while promoting good health. Bactana serves cattle farmers primarily in Connecticut and New York, with headquarters in Farmington, Connecticut.

Source Defense

Series A in 2018
Source Defense Ltd. is a cybersecurity company specializing in website security software that prevents attacks originating from third-party sources. Founded in 2014 and headquartered in Rosh-ha’ayin, Israel, with additional offices in Beer-Sheva and Stamford, Connecticut, the company offers a cloud-based Software-as-a-Service platform. This platform enables site owners to effectively manage their security by setting and enforcing permissions, receiving real-time alerts, and monitoring the activities of third-party vendors on their sites. Source Defense aims to eliminate the security risks associated with third-party integrations, allowing businesses to save significant time and resources while maintaining high performance and safety for site visitors. Its tailored solutions include VICE products designed for various sectors, including financial institutions, insurance companies, e-commerce, and publishing.

Inbox Health

Seed Round in 2018
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

Tunxis Community College

Grant in 2018
In the Farmington, Connecticut area, Tunxis Community College has academic, workforce training, and personal enrichment courses for students with all sorts of different interests that can earn you an associate’s degree or certificate. Among the many majors to choose from are programs such as Allied Health, Graphic Design, Visual Fine Arts, Business Office Technology, Computer Information Systems, Criminal Justice, Drug and Alcohol Recovery Counselor, Early Childhood Education, Engineering Science and Technology Studies, and New Media Communication, as well as many more. Counselors in the financial aid office can point you toward programs that will help you earn loans, grants, scholarships, veteran’s benefits, and more if you qualify. These financial aid options can help you pay for tuition and other expenses. Student life at TCC includes a student lounge, The Cyber Café, and the Barnes-Franklin Gallery, which is filled with student, community, and professional art. Academic advising is available for any student who needs help. The career center can help students find employment. Other student resources includes child care, health care, media center, and student activities.

Phlatbed

Venture Round in 2018
Phlatbed Inc. is an on-demand logistics application founded in 2016 and based in Norwalk, Connecticut. The platform connects consumers with local drivers who offer services for moving, packing, loading, and junk removal. Users can place real-time requests and select from multiple drivers based on geographic preferences, service pricing, and availability. Once a driver is accepted, payment is processed automatically through PayPal, credit card, or cash, and both parties can provide feedback on their experience. Phlatbed operates across the United States, Canada, and is expanding into the United Kingdom. The company promotes community engagement through an active blog and social media presence, aiming to eliminate waste and help individuals turn idle assets into revenue.

ReNetX Bio

Series A in 2018
ReNetX Bio is a biotechnology company focused on developing therapeutics to treat injury and damage to the central nervous system. It advances disease-modifying programs including Nogo Trap, a decoy receptor that blocks growth inhibitors to promote axonal regeneration, sprouting, and synaptic plasticity, with aims to restore function after spinal cord injury, stroke, and glaucoma. The company develops small-molecule oral compounds designed to intervene in CNS pathology by disrupting harmful protein interactions, such as blocking the binding of beta-amyloid oligomers to prion protein to support axonal regrowth. Based in New Haven, Connecticut, ReNetX Bio pursues therapies intended to address CNS conditions by promoting nerve fiber regrowth and functional recovery. The pipeline emphasizes treatments that modify disease progression and support neural repair after injury and in neurodegenerative contexts.

OncoSynergy

Series A in 2018
OncoSynergy is a biotechnology company founded in 2011 and headquartered in Greenwich, Connecticut. As a spin-out from the University of California, San Francisco, the company focuses on developing innovative immunotherapies aimed at improving outcomes for cancer patients with unmet medical needs. OncoSynergy's approach centers on Resistance Mechanism Inhibitors (RMIs), a novel class of therapeutics that targets multiple pathways involved in cancer progression. These therapies have shown significant preclinical efficacy both as standalone treatments and in combination with other therapies. By employing this transformative strategy, OncoSynergy seeks to provide oncologists with options that can lead to durable outcomes and potential cures for patients battling cancer.

Rallybio

Series A in 2018
Rallybio is a clinical-stage biopharmaceutical company focused on developing therapies for severe and rare diseases. Its programs cover hematology, immuno-inflammation, maternal-fetal health and metabolic disorders, with a lead candidate aimed at preventing fetal and neonatal alloimmune thrombocytopenia, a life-threatening condition that can cause bleeding in fetuses and newborns. Founded in 2018 and based in New Haven, Connecticut, Rallybio develops therapies across antibodies, small molecules and engineered proteins to address unmet needs in rare diseases. Guided by experienced biopharma leadership, the company emphasizes translating biology into transformative therapies for underserved patients.

GoNation

Venture Round in 2018
GoNation operates a mobile platform that connects users with local businesses across multiple states. It offers personalized user profiles for sharing and saving information, fostering connections within communities. Incorporated in 2011, the company is headquartered in Milford, Connecticut.

FallCall Solutions

Seed Round in 2018
Founded in 2015, FallCall Solutions develops fall detection applications for elderly individuals and their caregivers. Its flagship product, FallCall Now, distinguishes between low and high impact falls and notifies family members or central dispatch agencies in case of a fall event. Additionally, ElderCheck Now facilitates communication between the elderly population and their caregivers. The company's solutions operate on mobile ecosystems to maximize elder independence and caregiver peace of mind.

Biorez

Series C in 2018
Biorez is a medical device company that develops bioresorbable scaffold implants to regenerate functional musculoskeletal tissue in vivo. Its products include off-the-shelf implants for anterior cruciate ligament reconstruction that spare donor tissue, and PLLA-based devices for soft-tissue regeneration in the knee, such as the L-C Ligament; the company also markets GRAFT, an FDA 510(k)-cleared device for soft-tissue augmentation of the rotator cuff, along with related implants to support repairs during healing. Biorez uses poly-L-lactic acid polymers to stabilize surgical repairs while the body regenerates tissue, enabling rehabilitation. The company was founded in 2008 and is headquartered in New Haven, Connecticut.

GoNation

Funding Round in 2017
GoNation operates a mobile platform that connects users with local businesses across multiple states. It offers personalized user profiles for sharing and saving information, fostering connections within communities. Incorporated in 2011, the company is headquartered in Milford, Connecticut.

LambdaVision

Series A in 2017
LambdaVision designs and develops a retinal implant to restore vision for patients with degenerative retinal diseases, including retinitis pigmentosa and age-related macular degeneration. The company leverages a protein-based retinal prosthesis that uses bacteriorhodopsin, a light-activated protein, to stimulate retinal cells and help clinicians improve visual function. Founded in 2009 and based in Farmington, Connecticut, LambdaVision focuses on progressing a technology platform aimed at helping individuals with significant vision loss due to RP and AMD.

Bioarray Therapeutics

Series B in 2017
Bioarray Therapeutics, Inc. is a biotechnology company founded in 2009 and based in Farmington, Connecticut. The company focuses on developing proprietary predictive diagnostic tests aimed at improving cancer treatment outcomes. Its primary offering is a breast cancer response prediction test, which utilizes a gene expression profile to evaluate a patient's likelihood of responding to standard pre-surgery taxane-based chemotherapy options. By providing these predictive diagnostics, Bioarray Therapeutics seeks to enhance treatment efficacy and reduce the reliance on a trial-and-error approach in cancer care.

Wellinks

Venture Round in 2017
Wellinks specializes in wearable health technologies designed to enhance clinical outcomes. Founded in 2014, the company is renowned for its innovative smart strap that monitors scoliosis brace wear duration and tightness, empowering patients, parents, and doctors with real-time data for informed treatment decisions.

Edge2Web

Convertible Note in 2017
Founded in 2016, Edge2Web specializes in low-code tools for industrial companies. Its cloud-based visual tools enable rapid development and deployment of IIoT-style applications, improving operational performance.

IsoPlexis

Series B in 2017
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

The Big Willow

Convertible Note in 2017
The Big Willow, Inc. is a technology company that specializes in designing and developing marketing platforms aimed at enhancing buyer engagement and intent identification. Founded in 2013 and headquartered in Wilton, Connecticut, the company leverages advanced analytics to index content consumption across web sessions, linking off-site behavior to activity data from various marketing and sales tools. Its product offerings include a B2B-centric programmatic advertising platform designed around buyer intent, account-based marketing solutions, and pre-targeted advertising and custom content syndication services. The Big Willow also provides marketing technology solutions that drive account-based marketing initiatives and sales enablement solutions to expedite deal flow and increase revenue from qualified leads. By processing vast amounts of web data, the company helps clients uncover buying intent and optimize their marketing strategies to improve engagement with potential customers.

Cybrexa Therapeutics

Series B in 2017
Cybrexa Therapeutics is a biotechnology company focused on developing an innovative class of small molecule DNA repair inhibitors aimed at improving cancer treatment. Founded in 2016 and based in New Haven, Connecticut, Cybrexa utilizes a proprietary peptide-based technology that specifically targets the tumor microenvironment. This approach allows for enhanced drug delivery and increased therapeutic efficacy, particularly when combined with existing chemotherapies and radiotherapies. By enabling the safe administration of higher drug doses, Cybrexa's therapeutics aim to expand the efficacy of current anticancer agents and address significant unmet medical needs in oncology. The company's novel platform has the potential to redefine drug delivery paradigms and enhance patient outcomes in cancer care.

Trinity Mobile Networks

Venture Round in 2017
Trinity Mobile Networks, Inc. is a technology company based in New Haven, Connecticut, specializing in the development of a software-defined networking (SDN) platform tailored for smartphones and other mobile devices. The company's flagship product, TrinitySDN, facilitates the integration of cellular, Wi-Fi, and mesh connections, enabling enhanced data speed and network bandwidth. By utilizing its innovative platform, network operators can manage and monitor diverse network types, optimize traffic, and implement seamless handoffs between different connections. Trinity Mobile Networks also focuses on improving the performance of wireless mesh networks, providing users with affordable connectivity and reducing dependence on costly cellular services. The company’s solutions include real-time diagnostics, secure virtual sub-networks, and enhanced quality of service, all designed to operate efficiently within the constraints of mobile devices. Established in 2014, Trinity Mobile Networks aims to revolutionize the way mobile connectivity is experienced by leveraging advanced networking technologies.

Bactana Corporation

Seed Round in 2017
Bactana Corporation develops a nutritional product platform aimed at enhancing microbiome health in livestock and other animals. Its core product, FPS-4, manipulates immunometabolism to boost productivity while promoting good health. Bactana serves cattle farmers primarily in Connecticut and New York, with headquarters in Farmington, Connecticut.

Inbox Health

Seed Round in 2017
Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

SmartPay Solutions

Series A in 2016
SmartPay Solutions LLC, established in 2010 and headquartered in Southington, Connecticut, specializes in providing software solutions for pay-as-you-go workers' compensation plans. The company offers its SmartPay solution to insurance agents, insurance carriers, and payroll providers, facilitating a streamlined and efficient approach to managing workers' compensation insurance. By leveraging cloud-based technology, SmartPay Solutions enables its clients to access a virtual software platform that is designed to be user-friendly and adaptable to various needs. The company's innovative offerings enhance the experience for all stakeholders involved in the workers' compensation process.

Cadenza Innovation

Series A in 2016
Cadenza Innovation is a battery technology company that develops and licenses patented Li-ion battery designs and architectures for electric vehicles and energy storage applications. Its approach combines elements of wound jelly-roll and large prismatic cell concepts to deliver high energy density at lower cost, with a focus on safety, reliability, and long cycle life. The company targets automotive and energy storage markets, offering systems for power backup in hybrid, off-grid, and grid-connected telecom sites, and provides optional real-time monitoring and high-temperature performance configurations. Based in Wilton, Connecticut, the company was founded in 2012.

PayVeris

Venture Round in 2016
PayVeris, LLC is a cloud-based digital payment and money transfer platform that provides comprehensive solutions for both consumer and business bill payments, as well as external account-to-account transfers between various financial institutions. Founded in 2011 and headquartered in Cromwell, Connecticut, PayVeris enables person-to-person payments, allowing users to send money electronically from their bank or credit union accounts via web, smartphone, or tablet. The platform includes PayWatch, an integrated fraud prevention solution that monitors transactions for potential risks, and PayItNow, a service that connects financial institutions, merchants, and consumers in the payments process. PayVeris has established strategic partnerships with Kony and Corelation to enhance its offerings and expand its reach in the digital payments landscape.

Wellinks

Venture Round in 2016
Wellinks specializes in wearable health technologies designed to enhance clinical outcomes. Founded in 2014, the company is renowned for its innovative smart strap that monitors scoliosis brace wear duration and tightness, empowering patients, parents, and doctors with real-time data for informed treatment decisions.

ShopLandia

Convertible Note in 2015
Shoplandia, Inc. is a mobile application developer based in Stamford, Connecticut, established in 2014. The company offers a unique shoppable video platform that allows users to create, edit, and stream product videos for online sales. This end-to-end software as a service (SaaS) solution enables peer-to-peer selling through both recorded and live video formats. Users can customize their videos with various features, including music, filters, and special effects, facilitating a dynamic and engaging shopping experience. Shoplandia's innovative approach aims to streamline the process of showcasing products, making it easier for sellers to connect with potential buyers.

Arccos Golf

Venture Round in 2015
Founded in 2012, Arccos Golf develops and markets advanced golf performance tracking systems. Their flagship product, the Arccos Caddie platform, uses sensors attached to clubs and AI-powered analytics via a mobile app to provide real-time shot tracking, distance club averages, GPS rangefinder, and personalized caddie advice, helping golfers of all skill levels improve their game.

Chiefofstaff.com

Convertible Note in 2015
Chiefofstaff.com develops and operates a cloud-based strategic plan management platform. It enables users to measure, monitor, and manage the implementation of strategic plans within organizations. The platform offers real-time feedback on strategy elements, communicates with front-line managers, and provides CEOs with actionable insights for decision-making. It is customizable, scalable, and used by clients such as New York Life Mexico and Zodiac Aerospace.

SeeClickFix

Venture Round in 2015
SeeClickFix is a platform that enables residents to report non-emergency issues and helps governments track, manage, and respond to requests, promoting transparency and collaboration in local governance. The company offers tools for request management, work management, citizen engagement, and data analytics to improve data collection, service delivery, and reporting to stakeholders. Its backend centralizes every reported issue, while its mobile app brings city information into residents’ hands and its dashboards support data-driven decisions. SeeClickFix serves municipalities and educational institutions by facilitating issue reporting, service coordination, and public accountability, enabling officials to evaluate performance, plan improvements, and communicate outcomes to communities.

NorthPage

Venture Round in 2015
Founded in 2007, NorthPage Inc. offers a cloud-based digital marketing optimization platform that enables performance benchmarking, competitive analysis, and best-practice guidance for enterprise marketing organizations. Its solutions optimize websites, e-commerce sites, mobile marketing, social media, search engine marketing, content marketing, and e-retail programs, serving clients across retail, financial services, consumer product, pharmaceutical, and technology sectors.

Cafe Learn

Seed Round in 2015
Cafe Learn LLC is a cloud-based Software-as-a-Service platform based in Stamford, Connecticut, that enhances educational experiences for school students. Incorporated in 2015, the company enables instructors to create, share, and customize blended, social, and personalized courses, offering complete content flexibility. By focusing on student success, Cafe Learn provides educators with real-time data that tracks student mastery of measurable outcomes, thereby facilitating improved engagement and learning strategies. As a subsidiary of O'Donnell Group LLC, Cafe Learn aims to evolve teaching and learning methodologies within educational institutions.

Device42

Seed Round in 2015
Device42, Inc. is a software company that specializes in providing solutions for system, network, and data center engineers, as well as IT managers. Founded in 2010 and headquartered in West Haven, Connecticut, with an additional office in Boston, Massachusetts, Device42 offers a comprehensive suite of tools designed for IT inventory management, patch panel cable management, data center power management, and IP address tracking. Its platform includes essential features such as Configuration Management Database (CMDB), Application Dependency Mapping (ADM), and a DCIM Software Marketplace, all aimed at helping organizations maintain accurate inventories of both IP-based and non-IP assets. The software facilitates various IT operations, compliance auditing, migration, and modernization processes, making it easier for clients to manage hybrid IT environments and execute successful cloud migrations while ensuring compliance with internal and external regulations.

eBrevia

Seed Round in 2014
eBrevia Inc., established in 2011, specializes in developing artificial intelligence-driven software for legal professionals. Its primary products include Diligence Accelerator for streamlined due diligence processes, Contract Analyzer for efficient contract management, Lease Abstractor to simplify lease reviews, and Bespoke for custom term identification. These tools enable law firms and corporate legal departments to enhance accuracy, reduce time and costs associated with document review, and improve overall workflow efficiency. Headquartered in Stamford, Connecticut, with additional offices in San Francisco and New York, eBrevia operates as a subsidiary of Donnelley Financial Solutions Inc., following its acquisition in 2018. The company's innovative technology has been recognized through various awards, including the Startup America DEMO Competition and the Connecticut Technology Council's Most Promising Software Product of the Year award.

Fitscript

Seed Round in 2014
Fitscript LLC is a company that specializes in digital exercise programs aimed at diabetes prevention and weight management. The company's flagship application, GlucoseZone, offers a variety of exercise videos tailored to different needs, including total body workouts, chair exercises, core and abdominal routines, yoga, and strength training. Fitscript provides users with personalized exercise guidance based on their real-time glucose levels, diabetes conditions, and fitness goals, making it particularly beneficial for individuals with type 1 and type 2 diabetes. Type 1 users receive strategies to manage glucose fluctuations, while type 2 users are offered programs focused on weight loss. Originally founded as Exerscrip LLC in 2010, the company rebranded to Fitscript in April 2016 and is headquartered in New Haven, Connecticut.

New Haven Pharmaceuticals

Series B in 2014
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company focused on developing proprietary prescription medications that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs). The company aims to address significant therapeutic needs by offering innovative, controlled-release formulations that enhance dosing precision, safety, efficacy, and patient convenience. NHP's product pipeline leverages proprietary technologies and intellectual property licensed from Yale University, allowing the development of specialty drugs for new therapeutic indications. Through its innovative platform, NHP seeks to provide premium pharmaceutical solutions that meet the evolving needs of patients and healthcare providers.

Wellinks

Seed Round in 2014
Wellinks specializes in wearable health technologies designed to enhance clinical outcomes. Founded in 2014, the company is renowned for its innovative smart strap that monitors scoliosis brace wear duration and tightness, empowering patients, parents, and doctors with real-time data for informed treatment decisions.

GestVision

Seed Round in 2014
GestVision, Inc. is a medical diagnostics company based in Groton, Connecticut, focused on developing innovative solutions for the detection of preeclampsia in pregnant women. Established in 2014, the company has commercialized a point-of-care diagnostic test known as the Congo Red Dot urine test, which is designed to confirm or rule out preeclampsia. This pregnancy-related condition, characterized by high blood pressure and protein in the urine, poses significant health risks, including seizures and mortality if left untreated. GestVision aims to improve maternal and fetal health by providing effective diagnostic tools that enhance the detection and management of preeclampsia, addressing a growing concern in both developed and developing countries.

ZetrOZ

Grant in 2014
ZetrOZ specializes in innovative ultrasound technology. It manufactures and delivers therapeutic systems, including veterinary wearable ultrasound devices, high-intensity focused ultrasound systems for biomedical research, and various transducer control systems. The company's products cater to applications such as physiotherapy, drug delivery, ultrasonic sealing, cleaning, and sterilization. ZetrOZ was founded in 2009 and is headquartered in Trumbull, Connecticut.

IsoPlexis

Series A in 2014
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

SmartPay Solutions

Series A in 2014
SmartPay Solutions LLC, established in 2010 and headquartered in Southington, Connecticut, specializes in providing software solutions for pay-as-you-go workers' compensation plans. The company offers its SmartPay solution to insurance agents, insurance carriers, and payroll providers, facilitating a streamlined and efficient approach to managing workers' compensation insurance. By leveraging cloud-based technology, SmartPay Solutions enables its clients to access a virtual software platform that is designed to be user-friendly and adaptable to various needs. The company's innovative offerings enhance the experience for all stakeholders involved in the workers' compensation process.

P2 Science

Series A in 2014
Founded in 2009 by Yale scientists and a chemical industry veteran, P2 Science is a venture-backed company specializing in renewable specialty chemicals. It converts renewable feedstocks like vegetable oils into high-value products such as flavor, fragrance, and cosmetics ingredients, serving diverse markets including food, personal care, and industrial cleaning.

Avitus Orthopaedics

Seed Round in 2014
Avitus Orthopaedics, Inc. is a medical device company dedicated to developing and commercializing minimally invasive orthopedic surgical devices, specifically focusing on autologous bone graft harvesting. Founded in 2011 and headquartered in Shelton, Connecticut, the company offers innovative instruments, including the Avitus bone harvester, which is designed to efficiently harvest cancellous bone and marrow. Avitus Orthopaedics aims to enhance clinical outcomes and reduce healthcare costs through its advanced surgical technologies, contributing to improved patient care in reconstructive orthopedic surgeries. The company, formerly known as BOSS Medical, Inc., changed its name in March 2014 to reflect its commitment to orthopedic solutions.

GlyGenix Therapeutics

Seed Round in 2014
GlyGenix Therapeutics, Inc. is a biotechnology company focused on developing therapeutic products aimed at treating metabolic disorders. Specifically, the company works on manufacturing and delivering gene therapies to address Glycogen Storage Disease Type 1a (GSD1a). Founded in 2006 and headquartered in Woodbridge, Connecticut, GlyGenix Therapeutics collaborates with prominent institutions, including the National Institutes of Health, Duke University, the University of Florida, and Royal Philips Electronics, to advance its innovative approaches in gene therapy.

CashPath Financial

Seed Round in 2014
CashPath Financial LLC is a financial technology company based in Stamford, Connecticut, established in 2011. The company specializes in cash-flow management services, utilizing innovative technology to help individuals achieve everyday financial success. CashPath has developed a mobile application that predicts future cash flow, enabling users to understand how much they can spend on a daily, weekly, and monthly basis. By providing insights into spending and saving, the app aims to guide users towards positive cash flow, enhanced savings, and improved financial well-being. The company is currently preparing to launch a beta version of its mobile application, which will further facilitate users in planning for their financial growth.

Eli Nutrition

Seed Round in 2014
Eli Nutrition, Inc. is a company specializing in the development of antacid products. Founded in 2013 and based in New Haven, Connecticut, the company offers Tummyzen, a zinc-based over-the-counter antacid pill designed to provide relief from heartburn.

Biorez

Venture Round in 2014
Biorez is a medical device company that develops bioresorbable scaffold implants to regenerate functional musculoskeletal tissue in vivo. Its products include off-the-shelf implants for anterior cruciate ligament reconstruction that spare donor tissue, and PLLA-based devices for soft-tissue regeneration in the knee, such as the L-C Ligament; the company also markets GRAFT, an FDA 510(k)-cleared device for soft-tissue augmentation of the rotator cuff, along with related implants to support repairs during healing. Biorez uses poly-L-lactic acid polymers to stabilize surgical repairs while the body regenerates tissue, enabling rehabilitation. The company was founded in 2008 and is headquartered in New Haven, Connecticut.

CashPath Financial

Venture Round in 2013
CashPath Financial LLC is a financial technology company based in Stamford, Connecticut, established in 2011. The company specializes in cash-flow management services, utilizing innovative technology to help individuals achieve everyday financial success. CashPath has developed a mobile application that predicts future cash flow, enabling users to understand how much they can spend on a daily, weekly, and monthly basis. By providing insights into spending and saving, the app aims to guide users towards positive cash flow, enhanced savings, and improved financial well-being. The company is currently preparing to launch a beta version of its mobile application, which will further facilitate users in planning for their financial growth.

Precipio Diagnostics

Series B in 2013
Precipio Diagnostics is a cancer diagnostics company based in New Haven, Connecticut, specializing in clinical diagnostic services for hematopoietic cancers. The company offers advanced diagnostic products, including the HemeScreen panel for genetic mutation testing and the IV-Cell media, which enhances the accuracy of laboratory results. Precipio serves a diverse clientele, including oncologists, hospitals, reference laboratories, and pharmaceutical companies. In its commitment to improving cancer care, the company collaborates with prominent academic institutions such as the Yale School of Medicine and Dana-Farber Cancer Institute, fostering connections between physicians and leading pathologists. With laboratories in New Haven and Omaha, Precipio aims to reduce instances of cancer misdiagnoses and provide essential diagnostics to oncologists across the United States.

AxioMx

Venture Round in 2013
AxioMx Inc., founded in 2012 and based in Branford, Connecticut, specializes in the discovery, development, production, and delivery of recombinant antibodies. The company provides a comprehensive suite of custom antibody services, catering to the needs of life science researchers across diagnostic, pharmaceutical, biotechnology, and academic sectors. AxioMx's offerings include antigen and project design consultation, recombinant antibody development, antibody optimization, and protein production and purification services. Utilizing proprietary phage display libraries and affinity maturation techniques, the company excels in creating high-affinity, specific antibodies, including those for challenging targets such as phosphorylated proteins and non-immunogenic antigens. Additionally, AxioMx supports various antibody optimization processes, including scFv to IgG conversion and antibody labeling. The company is recognized for its innovative approach to synthetic recombinant antibodies, which serve vital roles in research, diagnostic tests, and therapeutic applications.

Arvinas

Series A in 2013
Arvinas, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, that specializes in the discovery, development, and commercialization of innovative therapies aimed at degrading disease-causing proteins. The company's lead product candidates include ARV-110, a proteolysis targeting chimera (PROTAC) currently in phase I clinical trials for metastatic castration-resistant prostate cancer, and ARV-471, which targets the estrogen receptor for patients with metastatic ER-positive/HER2-negative breast cancer. In addition to these, Arvinas is developing various other PROTACs aimed at degrading clinically relevant androgen receptor mutations and treatments for neurodegenerative diseases, including tauopathies. The company has established collaborations with prominent pharmaceutical firms such as Pfizer Inc., Genentech, and Bayer AG, enhancing its research capabilities and reach within the biopharmaceutical landscape. Founded in 2015, Arvinas aims to improve patient outcomes by eliminating harmful proteins from the body through its proprietary technology.

CaroGen Corporation

Seed Round in 2013
CaroGen Corporation is a biopharmaceutical company developing recombinant virus-like vesicles for vaccines against infectious diseases. Its platform technology enables the creation of vaccines targeting hepatitis B, C, influenza, and other viral agents.

American Oil Solutions

Seed Round in 2013
American Oil Solutions (AOS) is a green technology company based in Bridgeport, Connecticut, specializing in the recycling of used hydrocarbon products, particularly tires. The company employs a closed-loop, pollution-free process that transforms old tires into various valuable resources, including fuel oil, carbon products, syngas, scrap steel, and specialty chemicals. AOS aims to establish itself as a leader in the market for hydrocarbon product recycling by utilizing the readily available supply of tires, which allows for multiple product lines and revenue streams. Through its innovative technology, AOS contributes to environmental sustainability while addressing the challenges of waste management in the hydrocarbon sector.

ReadyDock

Seed Round in 2013
ReadyDock designs and manufactures multi-bay docking stations that securely store, charge, and disinfect mobile devices using chemical-free disinfection. Its flagship Duo Disinfection Station offers a slim, high-capacity unit capable of handling multiple large and small devices, including tablets for C5 and F5 series. The systems support device workflows across hospitals, education, retail, food service, and other settings that require secure charging, storage, and disinfection. Products are distributed through resellers. Founded in 2012, ReadyDock is headquartered in Avon, Connecticut.

Logicbroker

Series A in 2013
Logicbroker provides cloud-based automation technology for supply chains and digital commerce. It offers EDI and drop ship solutions that connect brands, retailers, and systems, along with tools for monitoring, reporting, and vendor performance management. Its platform enables clients to communicate throughout the order lifecycle with partners using a single connection endpoint. Logicbroker serves major clients such as Kroger, Coca-Cola, and Mattel.

AlloMek Therapeutics

Pre Seed Round in 2013
AlloMek Therapeutics is a privately held pharmaceutical company based in Farmington, Connecticut, focused on discovering and developing targeted therapies for cancer patients. Founded in 2010, the company specializes in inhibiting targets associated with the Ras pathway. AlloMek has developed a novel class of MEK kinase inhibitors that enhance the biopharmaceutical properties of previous MEK inhibitors. Their clinical candidate, CIP-1374, is an allosteric MEK kinase inhibitor effective against both MEK1/2 kinase and chemo-resistant ovarian cancer stem cells.

P2 Science

Seed Round in 2013
Founded in 2009 by Yale scientists and a chemical industry veteran, P2 Science is a venture-backed company specializing in renewable specialty chemicals. It converts renewable feedstocks like vegetable oils into high-value products such as flavor, fragrance, and cosmetics ingredients, serving diverse markets including food, personal care, and industrial cleaning.

eBrevia

Seed Round in 2013
eBrevia Inc., established in 2011, specializes in developing artificial intelligence-driven software for legal professionals. Its primary products include Diligence Accelerator for streamlined due diligence processes, Contract Analyzer for efficient contract management, Lease Abstractor to simplify lease reviews, and Bespoke for custom term identification. These tools enable law firms and corporate legal departments to enhance accuracy, reduce time and costs associated with document review, and improve overall workflow efficiency. Headquartered in Stamford, Connecticut, with additional offices in San Francisco and New York, eBrevia operates as a subsidiary of Donnelley Financial Solutions Inc., following its acquisition in 2018. The company's innovative technology has been recognized through various awards, including the Startup America DEMO Competition and the Connecticut Technology Council's Most Promising Software Product of the Year award.

Innovatient Solutions

Series A in 2013
Innovatient Solutions provides a patient engagement solution to the health care industry. They strive every day to enable patients to take more control of their health and to have more say in how they are cared for before, during, and after their hospital stay. It was founded in 2010 and headquartered in Farmington, Connecticut.

ZetrOZ

Series A in 2013
ZetrOZ specializes in innovative ultrasound technology. It manufactures and delivers therapeutic systems, including veterinary wearable ultrasound devices, high-intensity focused ultrasound systems for biomedical research, and various transducer control systems. The company's products cater to applications such as physiotherapy, drug delivery, ultrasonic sealing, cleaning, and sterilization. ZetrOZ was founded in 2009 and is headquartered in Trumbull, Connecticut.

ReadyDock

Seed Round in 2013
ReadyDock designs and manufactures multi-bay docking stations that securely store, charge, and disinfect mobile devices using chemical-free disinfection. Its flagship Duo Disinfection Station offers a slim, high-capacity unit capable of handling multiple large and small devices, including tablets for C5 and F5 series. The systems support device workflows across hospitals, education, retail, food service, and other settings that require secure charging, storage, and disinfection. Products are distributed through resellers. Founded in 2012, ReadyDock is headquartered in Avon, Connecticut.

P2 Science

Seed Round in 2013
Founded in 2009 by Yale scientists and a chemical industry veteran, P2 Science is a venture-backed company specializing in renewable specialty chemicals. It converts renewable feedstocks like vegetable oils into high-value products such as flavor, fragrance, and cosmetics ingredients, serving diverse markets including food, personal care, and industrial cleaning.

NorthPage

Venture Round in 2013
Founded in 2007, NorthPage Inc. offers a cloud-based digital marketing optimization platform that enables performance benchmarking, competitive analysis, and best-practice guidance for enterprise marketing organizations. Its solutions optimize websites, e-commerce sites, mobile marketing, social media, search engine marketing, content marketing, and e-retail programs, serving clients across retail, financial services, consumer product, pharmaceutical, and technology sectors.

eBrevia

Seed Round in 2013
eBrevia Inc., established in 2011, specializes in developing artificial intelligence-driven software for legal professionals. Its primary products include Diligence Accelerator for streamlined due diligence processes, Contract Analyzer for efficient contract management, Lease Abstractor to simplify lease reviews, and Bespoke for custom term identification. These tools enable law firms and corporate legal departments to enhance accuracy, reduce time and costs associated with document review, and improve overall workflow efficiency. Headquartered in Stamford, Connecticut, with additional offices in San Francisco and New York, eBrevia operates as a subsidiary of Donnelley Financial Solutions Inc., following its acquisition in 2018. The company's innovative technology has been recognized through various awards, including the Startup America DEMO Competition and the Connecticut Technology Council's Most Promising Software Product of the Year award.

NXT-ID

Seed Round in 2013
Nxt-ID, Inc. is a technology company focused on developing and marketing innovative solutions for healthcare applications, payment systems, and the Internet of Things (IoT). Founded in 2011 and headquartered in Oxford, Connecticut, the company specializes in areas such as access control, biometric identity verification, security, encryption, and data protection. Through its subsidiary, LogicMark LLC, Nxt-ID manufactures and distributes both non-monitored and monitored personal emergency response systems, primarily targeting dealers, distributors, and the United States Department of Veterans Affairs. The company serves a diverse range of markets, including security, healthcare, financial technology, and IoT.

CyVek

Series D in 2013
CyVek, Inc., established in 2008 and headquartered in Wallingford, Connecticut, specializes in developing a platform technology for measuring analytes in biological samples. The company offers an integrated test system comprising a microfluidic cartridge that enables the analysis of multiple biomarkers from minimal amounts of biological samples.

AxioMx

Venture Round in 2012
AxioMx Inc., founded in 2012 and based in Branford, Connecticut, specializes in the discovery, development, production, and delivery of recombinant antibodies. The company provides a comprehensive suite of custom antibody services, catering to the needs of life science researchers across diagnostic, pharmaceutical, biotechnology, and academic sectors. AxioMx's offerings include antigen and project design consultation, recombinant antibody development, antibody optimization, and protein production and purification services. Utilizing proprietary phage display libraries and affinity maturation techniques, the company excels in creating high-affinity, specific antibodies, including those for challenging targets such as phosphorylated proteins and non-immunogenic antigens. Additionally, AxioMx supports various antibody optimization processes, including scFv to IgG conversion and antibody labeling. The company is recognized for its innovative approach to synthetic recombinant antibodies, which serve vital roles in research, diagnostic tests, and therapeutic applications.

deets

Series A in 2012
Deets, Inc. is a mobile technology company based in Westport, Connecticut, founded in 2011 by former leaders from prominent online companies. It specializes in a mobile communication application available for both Android and iPhone users. The application facilitates organized group messaging, private sharing, and the customization of multiple user profiles. Furthermore, it includes features such as push notifications for group interactions and a dynamic synchronization of contacts, allowing users to manage group conversations and collaboration from a unified mobile dashboard. Deets aims to enhance productivity and meaningful communication through its innovative solutions.

Innovatient Solutions

Debt Financing in 2012
Innovatient Solutions provides a patient engagement solution to the health care industry. They strive every day to enable patients to take more control of their health and to have more say in how they are cared for before, during, and after their hospital stay. It was founded in 2010 and headquartered in Farmington, Connecticut.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.